Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Table 6 Number (%) of patients intolerant of each dose, safety population (n = 60)

Dose (mg)	Number of patients on this dose at any time, with data available on tolerability^a	Number (% of n) of patients intolerant of this dose at any time
10	55	1 (1.8)
20	54	3 (5.6)
30	47	2 (4.3)
35	41	3 (7.3)
40	34	1 (2.9)
45	32	4 (12.5)
50	31	8 (25.8)

^a Reduced numbers are as a result of patient withdrawals. Additionally, some patients titrated more slowly up the doses or never reached the higher doses.

ISSN: 1471-244X